Science and technology

Neural Processing Units, commonly referred to as NPUs, are purpose-built processors engineered to boost artificial intelligence and machine learning tasks. While CPUs manage broad, general operations and GPUs deliver exceptional parallel graphics and computation, NPUs concentrate on matrix calculations, inference processes, and highly efficient on-device training. In addition to NPUs, the wider family of AI chips encompasses dedicated accelerators embedded within system-on-a-chip architectures or supplied as standalone components for PCs and servers.Over the last half decade, AI workloads have steadily moved away from cloud‑first computation and toward on-device intelligence. This transition is fueled by calls for reduced latency, heightened privacy,…

Synthetic biology first gained prominence through its impact on pharmaceuticals, where engineered microbes produce insulin, vaccines, and complex biologic drugs. Over the past decade, the same core capabilities—precise genetic design, scalable fermentation, and data-driven optimization—have matured and become cost-effective enough to address challenges far beyond medicine. As a result, synthetic biology is now expanding rapidly into materials science, targeting sectors such as textiles, construction, packaging, and electronics.This expansion is driven by a convergence of technological readiness, market demand for sustainability, and limitations of traditional material manufacturing.Technological Enablers Behind the ExpansionMultiple technological breakthroughs have increasingly reduced the obstacles to using synthetic…

Drug discovery has long been a slow, costly, and high‑stakes endeavor, often requiring more than ten years and enormous financial investment before a single therapy reaches the market. Breakthroughs in artificial intelligence and protein folding tools are now transforming this process by greatly enhancing how researchers interpret biological targets, craft potential drug molecules, and anticipate their effects. As these innovations advance, development timelines are shrinking, expenses are decreasing, and therapeutic possibilities once considered unattainable are becoming viable.The Central Role of Protein Structure in Drug DiscoveryMost drugs work by binding to proteins and altering their activity. To design effective molecules, researchers…

Drug discovery has long been a slow, costly, and high‑stakes endeavor, often requiring more than ten years and enormous financial investment before a single therapy reaches the market. Breakthroughs in artificial intelligence and protein folding tools are now transforming this process by greatly enhancing how researchers interpret biological targets, craft potential drug molecules, and anticipate their effects. As these innovations advance, development timelines are shrinking, expenses are decreasing, and therapeutic possibilities once considered unattainable are becoming viable.The Central Role of Protein Structure in Drug DiscoveryMost drugs work by binding to proteins and altering their activity. To design effective molecules, researchers…